GL1X · GenesisL1 explorer

Research workbench

Structure of human dihydroorotate dehydrogenase in complex with ascofuranone (open-form)

Analyse Structure of human dihydroorotate dehydrogenase in complex with ascofuranone… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5ZFB
Type
protein
Length
367 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase (quinone), mitochondrial
EC
1.3.5.2
UniProt
Q02127
Ligands
FMN, ORO, 9BX, SO4
Pockets
5 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (quinone), mitochondrial (EC 1.3.5.2)protein36746% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • 9BX · 3-chloro-4,6-dihydroxy-5-[(2Z,6Z,8E)-11-hydroxy-3,7,11-trimethyl-10-oxododeca-2,6,8-trien-1-yl]-2-methylbenzaldehyde · ligand · chains A
  • SO4 · Sulfate ion · ion · 6 copies · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14750.840.9060FMN, ORO, 9BX
2830.560.8618empty
31040.440.7820empty
4840.420.7919SO4
5510.280.7515empty

Compared structures

  • 5ZFB · Structure of human dihydroorotate dehydrogenase in complex with ascofura (open-form) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.